Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health ...

Obeid emphasized that risk assessment is a critical part of ongoing cancer care. It helps patients and their families understand the cancer’s causes, informs treatment options and supports strategies ...

Genetic advances in Type 2 diabetes (T2D) have led to the discovery and validation of multiple markers for this complex disease. Despite low predictive value of current T2D markers beyond clinical ...

NEW YORK, Aug. 31 (UPI) --A single blood test that measures inflammation and fat can predict women's risk for cardiovascular disease 30 years later, a new Harvard study suggests. The findings, ...

Experts discuss how knowledge of lipoprotein(a) (Lp[a]) levels can empower patients in managing atherosclerotic cardiovascular disease (ASCVD) risk factors, how providers can collaborate with patients ...

Experts discuss atherosclerotic cardiovascular disease and aortic stenosis, as well as their burden, highlighting their prevalence, impact on patient health, and the growing need for effective ...

Lung cancer affects non-smokers, with 25% of patients having never smoked, highlighting the need for awareness of persistent symptoms and environmental risk factors. Genetic testing is essential for ...

Stress testing results—no matter the modality used to obtain them—predict prognosis among patients with stable, moderate-to-severe CAD, new data from the ISCHEMIA trial suggest. The study, published ...

Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...